Physician profile
Emily Bourne
NPI 1326616574
$4,616.80
in general payments reported to CMS, 2019-2025
35 companies · $342 in 2025
The $342 reported for 2025 was more than what 78% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.63 · 2022: $1,886 · 2023: $1,382 · 2024: $940 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,579 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,578.86 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $554.38 | 2022-2023 | Watchman Flx |
| Astellas Pharma US INC | $449.89 | 2022-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $407.73 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $382.31 | 2022-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $346.43 | 2022-2024 | |
| Amgen INC. | $265.81 | 2021-2022 | |
| Novo Nordisk INC | $225.58 | 2022-2024 | |
| Lilly USA, LLC | $219.05 | 2023-2024 | Mounjaro, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $170.17 | 2022 | |
| Axsome Therapeutics, INC. | $124.99 | 2025 | Auvelity |
| Glaxosmithkline, LLC. | $124.99 | 2023 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $124.84 | 2022 | |
| Idorsia Pharmaceuticals US INC | $123.63 | 2023 | Quviviq |
| Biosense Webster, INC. | $107.50 | 2024 | Carto 3 |
| Dexcom, INC. | $99.87 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $99.14 | 2022 | |
| Exeltis, USA INC. | $92.74 | 2022-2024 | Slynd |
| Pfizer INC. | $87.41 | 2022-2024 | |
| Eisai INC. | $86.36 | 2024 | |
| Xeris Pharmaceuticals, INC. | $83.62 | 2022 | |
| Janssen Pharmaceuticals, INC | $82.97 | 2022 | |
| Grt US Holding, INC. | $44.73 | 2022 | |
| Esperion Therapeutics, INC. | $35.10 | 2021-2022 | |
| Axonics, INC. | $34.28 | 2023-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $31.46 | 2023 | Gemtesa |
| Avion Pharmaceuticals | $31.41 | 2022-2023 | Balcoltra |
| Exact Sciences Corporation | $27.50 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $24.96 | 2023 | Aptima |
| Mayne Pharma Commercial LLC | $22.49 | 2023 | |
| Organon LLC | $20.31 | 2023 | Nexplanon |
| Kci USA, INC. | $20.27 | 2023 | Kerramax Care, Activ.A.C. |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.49 | 2022 | |
| Almatica Pharma LLC | $18.60 | 2021 | |
| Corcept Therapeutics | $14.91 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Bourne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.